Gene · 9757
Papers2,805
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,805
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Estrogen, Epigenetics, and Cardiometabolic Health: Mechanisms and Therapeutic Strategies in Postmenopausal Women. | Cells | 2026 | 41892319 | PubTator, text mining | PubMed |
| Analysis of HBV Genome Integration in Patients With HBV-Previously Infected NBNC-HCC. | Hepatol Res | 2026 | 41875012 | PubTator, text mining | PubMed |
| The JMJD family histone demethylases: structure, mechanism of action, diseases and therapeutic targets. | Mol Biomed | 2026 | 41857315 | PubTator, text mining | PubMed |
| Targeting Wnt/β-catenin and circadian regulator restores PRC2/EZH2-controlled chromatin bivalency and suppresses cell state diversity. | J Clin Invest | 2026 | 41842971 | PubTator, text mining | PubMed |
| A case report and literature review of duodenal adenocarcinoma with complete loss of mismatch repair proteins. | Front Oncol | 2026 | 41800032 | PubTator, text mining | PubMed |
| Comprehensive genomic profiling of triple-negative breast cancer metastases identifies role of PKD1 in immunotherapy resistance. | J Clin Invest | 2026 | 41766665 | PubTator, text mining | PubMed |
| Detection of germline variants in human population chronically exposed to high level natural background radiation in Kerala coast. | Genes Environ | 2026 | 41761368 | PubTator, text mining | PubMed |
| Direct Viral Mechanisms Underlying the Onset of HBV-Related Hepatocellular Carcinoma and Implications for Therapeutic Strategies. | Viruses | 2026 | 41754527 | PubTator, text mining | PubMed |
| Clinical Implications of Paternal Age in Assisted Reproduction: Integrating Sperm Epigenetic Evidence. | J Clin Med | 2026 | 41753012 | PubTator, text mining | PubMed |
| Genetic Traces in Autism Spectrum Disorders: A Whole Exome Sequencing Study from Türkiye. | Genes (Basel) | 2026 | 41751633 | PubTator, text mining | PubMed |
| KMT2B-related disorders in Austria: clinical features and long-term outcome after deep brain stimulation. | Front Neurol | 2026 | 41738007 | PubTator, text mining | PubMed |
| Clonal Dynamics and Molecular Heterogeneity of Metaplastic Breast Cancer: Focus on TP53 and PIK3CA Truncal Mutations. | Breast Cancer (Dove Med Press) | 2026 | 41737540 | PubTator, text mining | PubMed |
| The role of epigenetic modifications in hematological cancers. | Front Oncol | 2026 | 41727658 | PubTator, text mining | PubMed |
| Systematic multivariate analysis of chromatin complex dependencies reveals Set1C/COMPASS as a melanoma-enriched epigenetic vulnerability. | bioRxiv | 2026 | 41726895 | PubTator, text mining | PubMed |
| Comprehensive Genomic Profiling Across Diverse Solid Tumors: A Real-World Experience From India With FoundationOne®CDx Testing. | Cureus | 2026 | 41717185 | PubTator, text mining | PubMed |
| Aberrant epithelial differentiation may contribute to endometrial polyp formation: insights from single-cell analysis. | Syst Biol Reprod Med | 2026 | 41712676 | PubTator, text mining | PubMed |
| [Clinicopathological and molecular features of acquired cystic disease-associated renal cell carcinoma]. | Zhonghua Bing Li Xue Za Zhi | 2026 | 41644424 | PubTator, text mining | PubMed |
| Bile duct tumor thrombus (intraductal polypoid growth)-positive intrahepatic cholangiocarcinoma: clinicopathologic and genomic analysis. | J Pathol | 2026 | 41618619 | PubTator, text mining | PubMed |
| A tryptophan-phenylalanine binding motif for the histone methyltransferases MLL4 and MLL3. | J Biol Chem | 2026 | 41581869 | PubTator, text mining | PubMed |
| IGF2 supports glioblastoma growth and immune evasion through a combination of tumor cell-intrinsic and -extrinsic mechanisms. | Neurooncol Adv | 2026 | 41568176 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9757/papers?page=2